Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hay

Showing results (341-350 of 423) with videos related to

Pageof 43
Sort By:
The Oncologist|June 12, 2025
The Association of Health Care Contact Days with Economic Measures in the CCTG LY.12 TrialArjun Gupta, Tyler Thomas, Annette E Hay, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 19, 2020
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the LiteratureBethany E Monteith, Christopher P Venner, Donna E Reece, et al.
Infection and Immunity|December 11, 1997
Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachomaS Ghaem-Maghami, R L Bailey, D C Mabey, et al.
The Journal of Organic Chemistry|March 11, 2009
Antimalarial bromophycolides J-Q from the Fijian red alga Callophycus serratusAmy L Lane, E Paige Stout, An-Shen Lin, et al.
Hepatology (Baltimore, Md.)|January 1, 1995
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissueW J Sandborn, G M Lawson, T J Cody, et al.
Transplantation Proceedings|February 1, 1993
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipientsM K Porayko, S C Textor, R A Krom, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical TrialAnca Prica, Annette E Hay, Michael Crump, et al.
Current Oncology (Toronto, Ont.)|April 29, 2016
Accrual of adolescents and young adults with cancer to clinical trialsA E Hay, C Rae, G A Fraser, et al.
Osteoarthritis and Cartilage|June 18, 2021
Inhibition of sphingosine 1-phosphate protects mice against chondrocyte catabolism and osteoarthritisC Cherifi, A Latourte, S Vettorazzi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 30, 2008
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infectionB J Veldt, J J Poterucha, K D S Watt, et al.
Pageof 43

Showing results (341-350 of 423) with videos related to

Sort By:
Pageof 43
The Oncologist|June 12, 2025
The Association of Health Care Contact Days with Economic Measures in the CCTG LY.12 TrialArjun Gupta, Tyler Thomas, Annette E Hay, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 19, 2020
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the LiteratureBethany E Monteith, Christopher P Venner, Donna E Reece, et al.
Infection and Immunity|December 11, 1997
Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachomaS Ghaem-Maghami, R L Bailey, D C Mabey, et al.
The Journal of Organic Chemistry|March 11, 2009
Antimalarial bromophycolides J-Q from the Fijian red alga Callophycus serratusAmy L Lane, E Paige Stout, An-Shen Lin, et al.
Hepatology (Baltimore, Md.)|January 1, 1995
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissueW J Sandborn, G M Lawson, T J Cody, et al.
Transplantation Proceedings|February 1, 1993
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipientsM K Porayko, S C Textor, R A Krom, et al.
Current Oncology (Toronto, Ont.)|April 3, 2021
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical TrialAnca Prica, Annette E Hay, Michael Crump, et al.
Current Oncology (Toronto, Ont.)|April 29, 2016
Accrual of adolescents and young adults with cancer to clinical trialsA E Hay, C Rae, G A Fraser, et al.
Osteoarthritis and Cartilage|June 18, 2021
Inhibition of sphingosine 1-phosphate protects mice against chondrocyte catabolism and osteoarthritisC Cherifi, A Latourte, S Vettorazzi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 30, 2008
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infectionB J Veldt, J J Poterucha, K D S Watt, et al.
Pageof 43